Clinical and Experimental Pediatrics

All issues > Volume 56(6); 2013

Kim: Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis

Retraction

Published online: June 21, 2013

DOI: https://doi.org/10.3345/kjp.2013.56.6.269

Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis

Won Seop Kim, MD

Department of Pediatrics, Chungbuk National University, College of Medicine, Cheongju, Korea.

(open-access, http://creativecommons.org/licenses/by-nc/3.0/):

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Korean J Pediatr 2011;54:241-5.

http://dx.doi.org/10.3345/kjp.2011.54.6.241. PMID: 21949518 [PubMed]

The following article is being retracted as a part of the manuscript was plagiarized.

Yeong-Ho Rha, MD, PhD

Editor-in-Chief,

Korean J Pediatr

References

1. Kim WS. Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis. Korean J Pediatr 2011;54:241–245.
[Article] [PubMed] [PMC]